<SEC-DOCUMENT>0001193125-25-018871.txt : 20250203
<SEC-HEADER>0001193125-25-018871.hdr.sgml : 20250203
<ACCEPTANCE-DATETIME>20250203073831
ACCESSION NUMBER:		0001193125-25-018871
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20250201
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250203
DATE AS OF CHANGE:		20250203

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BAXTER INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000010456
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				360781620
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-04448
		FILM NUMBER:		25580641

	BUSINESS ADDRESS:	
		STREET 1:		ONE BAXTER PKWY
		STREET 2:		DF2-1W
		CITY:			DEERFIELD
		STATE:			IL
		ZIP:			60015
		BUSINESS PHONE:		8479482000

	MAIL ADDRESS:	
		STREET 1:		ONE BAXTER PARKWAY
		STREET 2:		DF2-1W
		CITY:			DEERFIELD
		STATE:			IL
		ZIP:			60015

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BAXTER TRAVENOL LABORATORIES INC
		DATE OF NAME CHANGE:	19880522

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BAXTER LABORATORIES INC
		DATE OF NAME CHANGE:	19760608
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d907276d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bax="http://www.baxter.com/20250201" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2025-02-01_to_2025-02-01">BAXTER INTERNATIONAL INC</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-326">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2025-02-01_to_2025-02-01">0000010456</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="bax-20250201.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-02-01_to_2025-02-01"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-02-01</xbrli:startDate> <xbrli:endDate>2025-02-01</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-CommonStock1.00PerValueMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock1.00PerValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-02-01</xbrli:startDate> <xbrli:endDate>2025-02-01</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-GlobalNotes13Due2025Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2025Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-02-01</xbrli:startDate> <xbrli:endDate>2025-02-01</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-GlobalNotes13Due2029Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2029Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-02-01</xbrli:startDate> <xbrli:endDate>2025-02-01</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-361">8-K</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">PURSUANT TO SECTION 13 OR 15(D)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">OF THE SECURITIES EXCHANGE ACT OF 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-02-01_to_2025-02-01" format="ixt:datemonthdayyearen" id="ixv-362">February 1, 2025</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">Baxter International Inc.</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:99%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2025-02-01_to_2025-02-01" format="ixt-sec:stateprovnameen" id="ixv-363">Delaware</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(State or other jurisdiction<br/>of incorporation)</span></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-364">1-4448</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-365">36-0781620</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Commission<br/>File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-366">One Baxter Parkway</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-367">Deerfield</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2025-02-01_to_2025-02-01" format="ixt-sec:stateprovnameen" id="ixv-368">Illinois</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-369">60015</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-370">(224)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-371">948-2000</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2025-02-01_to_2025-02-01" format="ixt-sec:boolballotbox" id="ixv-372">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2025-02-01_to_2025-02-01" format="ixt-sec:boolballotbox" id="ixv-373">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2025-02-01_to_2025-02-01" format="ixt-sec:boolballotbox" id="ixv-374">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR 240.14d 2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2025-02-01_to_2025-02-01" format="ixt-sec:boolballotbox" id="ixv-375">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br/>on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-CommonStock1.00PerValueMember" id="ixv-376">Common Stock, $1.00 par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-CommonStock1.00PerValueMember" id="ixv-377">BAX (NYSE)</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-CommonStock1.00PerValueMember" format="ixt-sec:exchnameen" id="ixv-378">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td colspan="3" style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center">Chicago Stock Exchange</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-GlobalNotes13Due2025Member" id="ixv-379">1.3% Global Notes due 2025</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-GlobalNotes13Due2025Member" id="ixv-380">BAX 25</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-GlobalNotes13Due2025Member" format="ixt-sec:exchnameen" id="ixv-381">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-GlobalNotes13Due2029Member" id="ixv-382">1.3% Global Notes due 2029</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-GlobalNotes13Due2029Member" id="ixv-383">BAX 29</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-GlobalNotes13Due2029Member" format="ixt-sec:exchnameen" id="ixv-384">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter):</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2025-02-01_to_2025-02-01" format="ixt-sec:boolballotbox" id="ixv-385">&#9744;</ix:nonNumeric> Emerging growth company</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act: &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;2.02 &#8195;&#8195;Results of Operations and Financial Condition. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&#160;3, 2025, Baxter International Inc. (the &#8220;Company&#8221;) announced that it expects its results for the fourth quarter and full year ended December&#160;31, 2024 to be aligned with the continuing operations guidance provided in the Company&#8217;s earnings release for the third quarter ended September&#160;30, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated herein by reference. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;5.02 &#8195;&#8195;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Transition of Jos&#233; Almeida as CEO and Chair; Appointment of Brent Shafer as Interim CEO and Chair </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&#160;3, 2025, the Company announced that, effective as of February&#160;3, 2025 (the &#8220;CEO Transition Date&#8221;), Jos&#233; E. Almeida&#8217;s service as Chief Executive Officer (&#8220;CEO&#8221;) of the Company, Chair of the Board of Directors (the &#8220;Board&#8221;) and director has ceased and, as of such date, Mr.&#160;Almeida has transitioned into a <span style="white-space:nowrap">non-executive</span> officer role (&#8220;Special Advisor&#8221;) and will continue employment with the Company through October&#160;31, 2025 (such date the &#8220;Separation Date&#8221;, and such period, the &#8220;Advisory Period&#8221;). As of the Separation Date, Mr.&#160;Almeida&#8217;s service relationship with the Company will cease. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&#160;3, 2025, the Company announced that, effective as of the CEO Transition Date, the Board appointed Brent Shafer as interim CEO of the Company and Chair of the Board. Effective as of the CEO Transition Date, Mr.&#160;Shafer resigned from his role as Lead Independent Director of the Board and as a member of the Audit Committee and Nominating, Corporate Governance and Public Policy Committee, and Nancy Schlichting was appointed Lead Independent Director. The Board has retained a leading search firm and has begun a process to select a permanent CEO, evaluating internal and external candidates. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Shafer does not have any family relationships with any of the Company&#8217;s directors or executive officers, there are no arrangements or understandings between Mr.&#160;Shafer and any other persons pursuant to which he was selected as an officer or director, and there are no transactions between Mr.&#160;Shafer and the Company that would be required to be reported under Item 404(a) of <span style="white-space:nowrap">Regulation&#160;S-K.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Shafer, age 67, has served as interim CEO and Chair of the Board since the CEO Transition Date and has served as a director of the Company since 2022. He served as the Lead Independent Director of the Board from 2023 to the CEO Transition Date. He is the former Chair and Chief Executive Officer of Cerner Corporation (&#8220;Cerner&#8221;), a leading provider of various health information technologies, ranging from medical devices to electronic health records to hardware, serving in this role from 2018 to 2021. Prior to Cerner, Mr.&#160;Shafer held a number of roles at Philips Healthcare (&#8220;Philips&#8221;), including Chief Executive Officer of Philips North America, a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Mr.&#160;Shafer was also the Chief Executive Officer of Philips Home Healthcare Solution business. Before joining Philips, Mr.&#160;Shafer was Vice President and General Manager of the Patient Care Environment Division of <span style="white-space:nowrap">Hill-Rom</span> Holdings, Inc. and worked at GE Medical Systems where he served in key positions in sales, marketing, and general management. Mr.&#160;Shafer has also held senior roles at Hewlett Packard&#8217;s Medical Products Group and Johnson&#160;&amp; Johnson. Mr.&#160;Shafer currently serves as a director of Tactile Systems Technology, Inc. (Nasdaq: TCMD) and Veracyte, Inc.(Nasdaq: VCYT). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Letter Agreement with Mr.&#160;Almeida </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&#160;1, 2025, the Company and Mr.&#160;Almeida entered into a letter agreement (the &#8220;Almeida Letter Agreement), pursuant to which (1)&#160;his service as CEO, Chair of the Board and director ceased as of the CEO Transition Date and (2)&#160;on the CEO Transition Date, he transitioned into the role of Special Advisor and will continue employment in such role through the Separation Date. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As compensation for services performed as Special Advisor during the Advisory Period, Mr.&#160;Almeida will receive a salary based on an annual rate of $650,000 and continue to be eligible for the Company&#8217;s health benefits. Mr.&#160;Almeida will not be eligible to receive any bonus under the Company&#8217;s Management Incentive Compensation Program (the &#8220;MICP&#8221;) or long-term incentive awards under the Company&#8217;s long-term incentive plan for his service during 2025. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Almeida&#8217;s outstanding equity awards will continue to vest in accordance with their terms through the Separation Date, and, subject to Mr.&#160;Almeida&#8217;s compliance with certain release requirements, he will receive a <span style="white-space:nowrap">lump-sum</span> separation payment equal to $6,890,000, payable no later than 60 days following the Separation Date. In addition, for the twenty-four month period immediately following the Separation Date, the Company will arrange to provide Mr.&#160;Almeida and his dependents health </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
insurance benefits substantially similar to those provided to him and his dependents immediately prior to the Separation Date (the &#8220;Post-Separation Health Benefits&#8221;). The Post-Separation Health Benefits will be eliminated if Mr.&#160;Almeida receives benefits of the same type during the twenty-four month period following the Separation Date. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Almeida Letter Agreement is attached hereto as Exhibit 10.1 and is incorporated herein by reference. The above descriptions are qualified in their entirety by reference to the terms of the Almeida Letter Agreement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Interim CEO Agreement with Brent Shafer </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&#160;1, 2025, the Company and Mr.&#160;Shafer entered into a letter agreement (the &#8220;Shafer Letter Agreement) establishing the terms of his service as interim CEO and Chair of the Board, with a term commencing on the CEO Transition Date ending on the earlier of the <span style="white-space:nowrap">six-month</span> anniversary of the CEO Transition Date and the first date of employment of the successor CEO (the &#8220;Term&#8221;). Mr.&#160;Shafer&#8217;s compensation during the Term will comprise an annual base salary payable at the rate of approximately $108,333 per month, a bonus of $600,000, payable upon the first regularly scheduled payroll date following completion of and subject to his continued service through the expiration of the Term, and a <span style="white-space:nowrap">one-time</span> grant of restricted stock units under the Company&#8217;s 2021 Incentive Plan with a target grant value of $2,500,000 (the &#8220;RSUs&#8221;). The RSUs will be granted as soon as administratively practicable following the CEO Transition Date and will vest upon the expiration of the Term, subject to Mr.&#160;Shafer&#8217;s continued employment with the Company through such date. During the Term, Mr.&#160;Shafer will be eligible to use Company or charter aircraft, as applicable, for any required business and commuting travel to Company offices, and the Company will reimburse Mr.&#160;Shafer to make him whole for any taxes incurred in connection with taxable income allocated to Mr.&#160;Shafer based on his commuting travel. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Shafer Letter Agreement is attached hereto as Exhibit 10.2 and is incorporated herein by reference. The above descriptions are qualified in their entirety by reference to the terms of the Shafer Letter Agreement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Appointment of Heather Knight as Chief Operating Officer </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&#160;3, 2025, the Company announced that, effective as of the CEO Transition Date, the Board has appointed Heather Knight as Executive Vice President, Chief Operating Officer and Interim Group President, Medical Products&#160;&amp; Therapies (&#8220;COO&#8221;) of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms.&#160;Knight does not have any family relationships with any of the Company&#8217;s directors or executive officers, there are no arrangements or understandings between Ms.&#160;Knight and any other persons pursuant to which she was selected as an officer, and there are no transactions between Ms.&#160;Knight and the Company that would be required to be reported under Item 404(a) of <span style="white-space:nowrap">Regulation&#160;S-K.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms.&#160;Knight, age 53,<span style="font-weight:bold"> </span>has led the Company&#8217;s Medical Products and Therapies segment since 2023. From 2021-2023, she served as president of the Company&#8217;s Americas region and the Company&#8217;s Acute Therapies, Clinical Nutrition, and Medication Delivery business units. She joined the Company in 2019 as general manager, U.S. Hospital Products. Throughout her <span style="white-space:nowrap">30-year</span> career in the healthcare industry, Ms.&#160;Knight has held numerous roles of increasing leadership in general management, global upstream and commercial capacities at companies including Medtronic plc (&#8220;Medtronic&#8221;), Covidien plc (&#8220;Covidien&#8221;), Tyco International plc and Kendall Healthcare Products Company. Prior to joining the Company, she most recently served as vice president and general manager in Medtronic&#8217;s Surgical Innovations business. Ms.&#160;Knight earned her bachelor&#8217;s degree in Biological Sciences from the&#160;University of Buffalo and completed the Executive Sales Strategy and Management program from the University of Chicago Booth School of Management. Ms.&#160;Knight currently serves as a director of Waters Corporation (NYSE: WAT). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with her appointment as COO, effective as of the CEO Transition Date, Ms.&#160;Knight&#8217;s (i)&#160;annual target bonus under the MICP increased to 110% and (ii)&#160;annual target long-term incentive award under the Company&#8217;s long-term incentive plan increased to $5,000,000. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Formation of Operating Committee of the Board </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, on February&#160;3, 2025, the Board also announced that, effective as of the CEO Transition Date, the Board has formed a new operating committee (the &#8220;Operating Committee&#8221;) consisting of existing Board members to assist management and the Board in reviewing and identifying opportunities for improvement in the Company&#8217;s plans and strategies related to product development, manufacturing, distribution, growth and operational efficiency throughout the CEO transition. Unless the Board should otherwise determine to extend the term of the Operating Committee, it will dissolve automatically on the date that is six months following the Board&#8217;s appointment of a successor for the interim CEO. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;7.01 &#8195;&#8195;Regulation FD Disclosure </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&#160;3, 2025, the Company issued a press release announcing, among other things, Mr.&#160;Almeida&#8217;s departure, the appointment of Mr.&#160;Shafer as the Company&#8217;s interim CEO and Chair and Ms.&#160;Knight&#8217;s appointment as COO. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on <span style="white-space:nowrap">Form&#160;8-K&#160;and</span> is incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Given this announcement, the timing of the Company&#8217;s investor conference will be dependent on the appointment of a permanent CEO. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information in Item 2.02 and Item 7.01, including Exhibit 99.1 to this Current Report on <span style="white-space:nowrap">Form&#160;8-K,&#160;shall</span> not be deemed filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except in the event that the Company expressly states that such information is to be considered filed under the Exchange Act or incorporates it by specific reference in such filing. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;9.01 &#8195;&#8195;Financial Statements and Exhibits. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:7%"/>
<td style="width:90%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"><span style="font-weight:bold">Exhibit&#160;No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Description of Exhibits</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d907276dex101.htm">Letter Agreement, dated February&#160;1, 2025, by and between Jos&#233; E. Almeida and the Company </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d907276dex102.htm">Letter Agreement, dated February&#160;1, 2025, by and between Brent Shafer and the Company </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d907276dex991.htm">Press Release, dated February&#160;3, 2025 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:48%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:2%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">BAXTER INTERNATIONAL INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: February&#160;3, 2025</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ellen K. Bradford</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Name: Ellen K. Bradford</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Title: Senior Vice President and Corporate Secretary</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">5 </p>

</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d907276dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">February&nbsp;1, 2025 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jos&eacute; E. Almeida
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the Address on File with the Company </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Joe: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This letter (this &#147;<U>Letter</U>&#148;) confirms our mutual understanding regarding the transition of your employment with Baxter
International, Inc. (the &#147;<U>Company</U>&#148;). On behalf of the Board of Directors of the Company (the &#147;<U>Board</U>&#148;), I want to thank you for your years of leadership of the Company. Reference is made to that amended offer letter
between you and the Company, dated as of July&nbsp;25, 2023 (your &#147;<U>Offer Letter</U>&#148;) and that change in control agreement between you and the Company, dated as of September&nbsp;24, 2020 (your &#147;<U>CIC Agreement</U>&#148;).
Capitalized terms used but not defined in this Letter will have the meaning ascribed to them in your CIC Agreement. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Transition</B>.<B> </B>Your service as Chief Executive Officer of the Company, Chair of the Board and
Director will cease on February&nbsp;3, 2025 (the &#147;<U>Transition Date</U>&#148;), and, concurrently therewith, you will execute the Resignation Letter attached hereto as <B>Annex A</B>, pursuant to which you will voluntarily and irrevocably
resign as a director, member or officer of the Company and of each of its subsidiaries (collectively, the &#147;<U>Group</U>&#148;) and as a member of any committee of the Group or any board of directors, board of managers or special subcommittee
thereof. On the Transition Date, you will transition into a <FONT STYLE="white-space:nowrap">non-executive</FONT> officer employee role (&#147;<U>Advisor</U>&#148;) and continue service in such role through October&nbsp;31, 2025, or, if earlier,
upon your death or Disability or termination by the Company for Cause (such date, the &#147;<U>Separation Date</U>&#148;, and such period, the &#147;<U>Advisory Period</U>&#148;). The Company will not terminate the Advisory Period other than as a
result of you committing Cause. Your service relationship with the Company will end on the Separation Date. Both you and the Company hereby waive any otherwise existing notice requirements under any previous agreements or arrangements you have with
the Company. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">While serving as Advisor, you will provide advice and counsel as may reasonably be requested by the interim
or permanent CEO (as applicable, the &#147;<U>CEO</U>&#148;) from time to time and perform such other reasonable duties as may be assigned to you by the CEO commensurate with your knowledge and prior position as CEO. During the Advisory Period, you
will not accept outside employment or other service obligations but may continue to serve in your current director or advisor roles with outside companies; provided, that, subject to the approval of the Board which shall not be unreasonably
conditioned, delayed or withheld, you may provide outside director or advisor services to other entities during the Advisory Period so long as such services are not in violation of any restrictive covenants you are subject to and do not conflict
with or materially interfere with your duties to the Company. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Advisory Period Compensation</B>.<B> </B>Subject to your continued service as Advisor and compliance with
the Release Requirement (as defined below), while serving as Advisor, you will continue to be eligible to participate in the Company&#146;s health and other benefits and receive salary payable on the Company&#146;s regular payroll schedule based on
an annual rate of $650,000 but will not be eligible for any annual incentive plan (MICP) opportunity or long-term incentive awards for your service during 2025. For the avoidance of doubt, you will be eligible for a full-year bonus based on actual
corporate performance under the MICP for your service during 2024, and no individualized negative discretion will be applied to your MICP bonus. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Separation Benefits</B>. Subject to your compliance with the Release Requirement (as defined below), the
Company shall pay you a <FONT STYLE="white-space:nowrap">lump-sum</FONT> separation payment equal to two times your annual base salary and annual target bonus as of immediately prior to the Transition Date payable no later than 60 days following the
Separation Date. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In addition, for the twenty-four month period immediately following the Separation Date, the
Company will arrange to provide you and your dependents health insurance benefits substantially equivalent to those provided to you and your dependents immediately prior to the Separation Date, at no greater
<FONT STYLE="white-space:nowrap">after-tax</FONT> costs to you than the <FONT STYLE="white-space:nowrap">after-tax</FONT> cost to you immediately prior to the Separation Date; provided, however, that such health benefits shall be provided, as
applicable, through an arrangement that satisfies the requirements of Section&nbsp;105 or 106 of the Internal Revenue Code (the &#147;<U>Code</U>&#148;) and, to the extent the payments represent a reimbursement of expenses incurred by you, shall be
paid not later than the last day of the year following the year in which the underlying expenses were incurred. Benefits otherwise receivable by you pursuant to this paragraph shall be eliminated if benefits of the same type and level are received
by or made available to you during the twenty-four (24)&nbsp;month period following the Separation Date (and any such benefits received by or made available to you shall be reported to the Company by you). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">You hereby acknowledge that the foregoing benefits are in full satisfaction of any termination-related benefits due to you under any
arrangements or agreements with the Company. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Equity Awards Treatment</B>. Subject to your continued service as Advisor and compliance with the Release
Requirement (as defined below), your equity awards will continue to vest through the Separation Date and remain subject to the terms of the applicable award agreements, the applicable long-term incentive plan and your Offer Letter (including, as
applicable, retirement treatment). For the avoidance of doubt, your separation as of the Separation Date for any reason other than for Cause or as a result of your death or Disability shall be deemed a &#147;Qualifying Retirement&#148; under the
terms of your outstanding awards under the Company&#146;s 2021 Incentive Plan, which are included in the schedule of your equity holdings which is attached hereto as <B>Exhibit A</B>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Release Requirement</B>. You (or, in the case of your death, your beneficiaries or estate) agree to execute
and cause to become irrevocable the release attached hereto as <B>Annex B</B><B></B>&nbsp;within forty-five (45)&nbsp;days after the Transition Date and a supplemental release and general waiver in a substantially similar form that is acceptable to
the Company (each, a &#147;<U>Release</U>&#148;) within forty-five (45)&nbsp;days after the Separation Date (the &#147;<U>Release Requirement</U>&#148;). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Restrictive Covenants</B>.<B> </B>You will continue to abide by the restrictive covenants set forth in
Section&nbsp;9 of the CIC Agreement (outside of the context of the CIC Agreement) and all other obligations set forth in any contract or agreement with the Company which contain restrictive covenants related to confidentiality, <FONT
STYLE="white-space:nowrap">non-competition,</FONT> <FONT STYLE="white-space:nowrap">non-solicitation,</FONT> and intellectual property ownership (including without limitation that certain Agreement Regarding Competition and Protection of Proprietary
Interests between you and the Company (the &#147;<U>CPPI</U>&#148;)) (collectively, the &#147;<U>Restrictive Covenants</U>&#148;). The Restrictive Covenants are incorporated herein by reference and shall remain in full force and effect, in each
case, subject to and, if applicable, as modified by, the terms and conditions set forth in <B>Annex C</B>. You understand that nothing in this Letter (including <B>Annex C</B>), the CIC Agreement, the CPPI, a Release, or any other agreement between
you and the Company, shall in any way limit or prohibit you from engaging in any Protected Activity. &#147;<U>Protected Activity</U>&#148; shall mean filing a charge, complaint, or report with, or otherwise communicating with, cooperating with,
providing information to, responding to any inquiries from or participating in any investigation or proceeding that may be conducted by, any federal, state or local government agency or commission, including the Securities and Exchange Commission,
the Equal Employment Opportunity Commission, the Occupational Safety and Health Administration, and the National Labor Relations Board (&#147;<U>Agencies</U>&#148;), or discussing the terms and conditions of your employment with others to the extent
expressly permitted by Section&nbsp;7 of the National Labor Relations Act. You understand that in connection with such Protected Activity, you are permitted to disclose documents or other information to Agencies as permitted by law, and without
giving notice to, or receiving authorization from, the Company. Notwithstanding the foregoing, you agree to take all reasonable precautions to prevent any unauthorized use or disclosure of any information that may constitute confidential information
of the Company to any parties other than the relevant Agencies. You further understand that &#147;Protected Activity&#148; does not include the disclosure of any Company attorney-client privileged communications, and that any such disclosure without
the Company&#146;s written consent shall constitute a material breach of this Letter. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Withholding; Section</B><B></B><B>&nbsp;409A</B>. All payments to you from the Company will continue to be
subject to tax and other withholding and deductions, as required or permitted by applicable law and Company policies. All payments and awards to you from the Company will continue to be subject to any clawback policy of the Company to the extent
applicable. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The payments under this Letter are intended to comply with or be exempt from
Section&nbsp;409A of the Code, so you are not subject to penalties that may be imposed under 409A. For purposes of Section&nbsp;409A, each payment made under this Letter will be treated as a separate payment. In no event may you, directly or
indirectly, designate the calendar year of payment. This Letter shall be interpreted consistent with that intent, and, to the extent any provision hereof would result in your payment of such taxes or penalties, this letter would be amended in a
manner to bring it into compliance with 409A and preserve as possible the economic value of the relevant consideration. Notwithstanding any provision of this letter to the contrary, if and solely to the extent necessary to comply with the
restriction in Section&nbsp;409A(a)(2)(B) of the Code concerning payments to &#147;specified employees&#148; (as defined in Section&nbsp;409A) any payment on account of your separation from service that would otherwise be due hereunder within six
months after such separation will nonetheless be delayed until the first business day of the seventh month following your date of termination and the first such payment will include the cumulative amount of any payments that would have been paid
prior to such date if not for such restriction. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Indemnification</B>.<B> </B>The Company shall indemnify you for your actions or inactions through and during
the Advisory Period and shall provide continued D&amp;O coverage for your actions or inactions on or prior to the Transition Date. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Legal Fees</B>. The Company shall reimburse you up to thirty-five thousand dollars ($35,000) for the legal
fees reasonably incurred by you in connection with the negotiation and documentation of this Letter; provided that, upon request by the Company, you provide the Company with reasonable documentation of such fees. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Entire Agreement</B>. Except as expressly provided herein or in the Release, this Letter, together with the
Release, supersedes any other agreements or representations, oral or otherwise, express or implied, with respect to the subject matter hereof which have been made by either party, including, without limitation, your Offer Letter and your CIC
Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Counterparts</B>. This Letter may be executed in several counterparts, each of which shall be deemed to be
an original but all of which together will constitute one and the same instrument. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Choice of Law; Disputes</B>. The validity, interpretation, construction and performance of this Letter shall
be governed by the laws of the State of Illinois. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">All claims by you for benefits under this Letter shall be directed to
and determined by the Board and shall be in writing. Any denial by the Board of a claim for benefits under this Letter shall be delivered to you in writing and shall set forth the specific reasons for the denial and the specific provisions of this
Letter relied upon. The Board shall afford a reasonable opportunity to you for a review of the decision denying a claim and shall further allow you to appeal to the Board a decision of the Board within sixty (60)&nbsp;days after notification by the
Board that your claim has been denied. Notwithstanding the above, in the event of any dispute, any decision by the Board hereunder shall be subject to a de novo review by the arbitrator in accordance with the immediately following paragraph. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Any further dispute or controversy arising under or in connection with this Letter shall be settled exclusively by arbitration in Chicago,
Illinois, in accordance with the rules of the American Arbitration Association then in effect. Judgment may be entered on the arbitrator&#146;s award in any court having jurisdiction. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">You acknowledge that the Company may be irreparably injured by a violation of Section&nbsp;6 hereof, and you agree that the Company,
notwithstanding the foregoing provisions of this Section&nbsp;12 and in addition to any other remedies available to it for such breach or threatened breach, shall be entitled to seek a preliminary injunction, temporary restraining order, or other
equivalent relief, restraining the Executive from any actual or threatened breach of Section&nbsp;6. If a bond is required to be posted in order for the Company to secure an injunction or other equitable remedy, the parties agree that said bond need
not be more than a nominal sum. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Reporting and Messaging.</B> The Company agrees to provide you with a reasonable opportunity to review, and
will consider any reasonable comments on, the press release and internal communications regarding your transition, prior to filing or other public disclosure or dissemination thereof. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">* * * </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="79%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Baxter International Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brent Shafer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Brent Shafer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Lead Independent Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Cathy R. Smith</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Cathy R. Smith</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Title: Nominating, Corporate Governance&nbsp;&amp; Public Policy Committee Chair</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Nancy M. Schlichting</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Nancy M. Schlichting</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Title: Compensation and Human Capital Committee Chair</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Accepted and Agreed:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jos&eacute; E. Almeida</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jos&eacute; E. Almeida</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: February&nbsp;1, 2025</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>d907276dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">February&nbsp;1, 2025 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Brent Shafer </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the address on file with the Company </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Brent, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of the Board of Directors (the &#147;<U>Board</U>&#148;) of Baxter International Inc. (the &#147;<U>Company</U>&#148;), we are pleased to confirm
the terms of your service as Interim Chief Executive Officer and Chair of the Board (&#147;<U>Interim CEO/Chair</U>&#148;), effective February&nbsp;3, 2025 (the &#147;<U>Start Date</U>&#148;). </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Duties; Term</B>. As Interim CEO/Chair, you will report directly to the Board and will perform such duties,
consistent with the Interim CEO/Chair position, as will reasonably be assigned to you by the Board. This is intended to be a temporary position with a term ending on the earlier of the six (6)-month anniversary of the Start Date or the first date of
employment of your successor as Chief Executive Officer (the &#147;<U>Term</U>&#148;). You and the Board may elect to extend the Term upon mutually agreed terms. During the Term, you will remain a member of the Board, and immediately following the
Term you will return to being a <FONT STYLE="white-space:nowrap">non-employee</FONT> member of the Board. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Base Salary</B>. You will receive compensation at the rate of $108,333.33 per month (equivalent to annualized
compensation of $1,300,000) payable in accordance with the Company&#146;s normal payroll practices. If you and the Board elect to extend the Term, your base compensation rate shall be mutually agreed between you and the Board. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Bonus Eligibility</B>. You will be eligible for a bonus equal to $600,000, which shall be earned and payable
upon the first regular payroll date following completion of, and subject to your continued employment as Interim CEO/Chair through, the Term. You will not otherwise be eligible to participate in any bonus program of the Company.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Equity Award</B>.<B> </B>You will receive a <FONT STYLE="white-space:nowrap">one-time</FONT> grant of
restricted stock units with a target grant value of $2,500,000 (the &#147;<U>RSUs</U>&#148;) under the Company&#146;s 2021 Incentive Plan, as soon as administratively practicable after the Start Date. The RSUs will vest upon the end of the Term,
subject to your continued employment with the Company through such date. The RSUs will be subject to the terms and conditions of the Company&#146;s 2021 Incentive Plan and applicable award agreement. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Other Benefits</B>. During your service as Interim CEO/Chair, you will be eligible for reimbursement of
reasonable business expenses in accordance with the Company&#146;s policies as in effect from time to time. In addition, you will be eligible to use the Company aircraft or, if unavailable, charter aircraft, for any required business and commuting
travel to Company offices. The Company will reimburse you to make you whole for any taxes you incur in connection with taxable income allocated to you based on your commuting travel (which includes any taxes payable in connection with any tax gross
up paid to you). </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">You will not be eligible to participate in the Company&#146;s severance plans, and during the Term, you
will not be eligible for compensation (either in cash or equity) under the Company&#146;s <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation program. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Related Events and Agreements</B>. You hereby resign from your position as Lead Independent Director of the
Board and as a member of any committee of the Board on which you currently serve. The Company expects that, upon request following the Start Date, you will enter into a standard time sharing agreement and confidentiality agreement, with such terms
consistent with your interim and limited employment with the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>No Conflicts</B>. The Company acknowledges that you are currently serving as a member of the board of
directors of Tactile Systems Technology, Inc. and Veracyte, Inc. and agrees that your service of the board of directors of these companies may continue during your service as Interim CEO/Chair. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><FONT STYLE="white-space:nowrap">At-Will</FONT> Employment</B>. The term of your employment is &#147;at
will,&#148; which means that you or the Company may end your employment at any time and for any reason or no reason. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Withholding; Recoupment</B>. All payments to you from the Company will be subject to tax and other withholding
and deductions, as required or permitted by applicable law and Company policies, and all payments and awards to you from the Company will be subject to Baxter&#146;s Executive Compensation Recoupment Policy and any such other applicable policy for
clawback or recoupment of incentive compensation as may subsequently be approved from time to time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Legal Fees</B>. The Company will reimburse you up to $30,000 for the legal fees reasonably incurred by you in
connection with the negotiation and documentation of this offer letter; provided that, upon request by the Company, you provide the Company with reasonable documentation of such fees. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Entire Agreement</B>. This offer letter constitutes the full and entire understanding and agreement between
you and the Company with regard to the subject matters hereof and supersedes all prior understandings and agreements, written or oral, relating to the matters set forth herein. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Choice of Law</B>. The validity, interpretation, construction and performance of this offer letter shall be
governed by the laws of the State of Illinois. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Counterparts</B>. This offer letter may be executed in several counterparts, each of which shall be deemed to
be an original but all of which together will constitute one and the same instrument. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are confident that you will make a significant
contribution to the Company during this period of transition. Please indicate your acceptance by signing this offer letter. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Baxter Board of Directors by</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Nancy M. Schlichting, Compensation and Human Capital Committee Chair</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Nancy M. Schlichting</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Cathy R. Smith, Nominating, Corporate Governance&nbsp;&amp; Public Policy Committee Chair</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Cathy R. Smith</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Accepted by:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Brent Shafer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brent Shafer</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Interim CEO Letter</I>] </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>d907276dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g907276g68i98.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BAXTER ANNOUNCES CEO RETIREMENT AND APPOINTMENT OF COO </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Jos&eacute; (Joe) E. Almeida to retire as Chair, President and Chief Executive Officer </I>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Lead Independent Director Brent Shafer appointed Chair and Interim CEO </I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Board has initiated a comprehensive search to select full-time replacement</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Heather Knight appointed Chief Operating Officer </I> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>DEERFIELD, Ill., FEB. 3, 2025</B> &#150; Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that Jos&eacute;
(Joe) E. Almeida, chair, president and chief executive officer (CEO), will retire from his executive roles with the company, effective immediately. He will serve in an advisory capacity through Oct. 31, 2025. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Baxter Board of Directors has appointed lead independent director Brent Shafer as chair and interim CEO and has initiated a search for a
permanent CEO with the assistance of a leading search firm. The Board will evaluate external and internal candidates. In conjunction with his appointment, Brent Shafer is stepping down from his role as lead independent director. Baxter director
Nancy Schlichting will assume the role of lead independent director. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;On behalf of the Board, I would like to thank Joe for his
leadership and unwavering dedication to Baxter throughout his nine years of service,&#148; said Mr. Shafer. &#147;Joe has guided the company through a period of significant evolution and portfolio repositioning, including the recently closed sale of
its Kidney Care business, while navigating market challenges and evolving conditions. Thanks to his leadership, today&#146;s Baxter is better able to fulfill its mission of saving and sustaining lives while delivering increased value for patients,
customers, employees and its many other stakeholders. I look forward to supporting Baxter&#146;s important work in service of its mission and working closely with the Board to identify the permanent CEO.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;It has been an immense honor to lead the exceptionally talented Baxter team, which is united by our mission and passionate about serving
the more than 350 million patients who count on us every year. With the key elements of our broad strategic transformation complete, this is the right time for a new CEO to lead the company into its next chapter,&#148; said Mr. Almeida. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Almeida assumed his roles at the company in January 2016, following more than three decades of distinguished contributions to the
healthcare industry. Under his leadership, Baxter </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g907276g68i98.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">meaningfully evolved its strategic positioning, reorienting the company toward higher-growth
<FONT STYLE="white-space:nowrap">end-markets.</FONT> This strategic shift has most recently centered on the simplification of the business through the divestment of certain <FONT STYLE="white-space:nowrap">non-core</FONT> assets and the
implementation of a new operating model to accelerate innovation and deliver value. During Mr.&nbsp;Almeida&#146;s tenure, the company has also been widely recognized as a socially responsible and sustainable business and as an employer of choice.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Appointment of Chief Operating Officer </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Baxter has appointed Heather Knight to the role of executive vice president and chief operating officer (COO), effective immediately. As COO,
Ms.&nbsp;Knight will have responsibility for the company&#146;s <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> business operations, including global sales, marketing, R&amp;D, supply chain and medical and
regulatory affairs. She will report directly to the interim CEO and will also serve as interim group president, Medical Products&nbsp;&amp; Therapies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Unifying leadership and oversight of operations across our three post-separation businesses is a natural step in our transformation,
best positioning the company to capitalize on our segment operating structure and drive incremental growth through innovation,&#148; said Mr.&nbsp;Shafer. &#147;Heather&#146;s decades of operational expertise and leadership and deep knowledge of the
global commercial, operational, medical and regulatory landscape will continue to serve our patients, customers and Baxter well going forward.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;I&#146;m excited to assume this new role within Baxter, expanding my focus on operational excellence and performance execution across
our organization,&#148; said Ms.&nbsp;Knight of her appointment. &#147;Every day I am driven by our mission, and I am inspired by the opportunity we have before us to further advance Baxter for the benefit of patients and healthcare professionals
around the world.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Kidney Care Sale and Financial Outlook </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The company completed the sale of its Kidney Care business to Carlyle on Jan. 31, 2025. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The company will now report its fourth-quarter and full-year 2024 earnings results on Feb. 20, 2025. Baxter expects results for the fourth
quarter and full-year 2024 to be aligned with the continuing operations guidance previously provided in the company&#146;s third-quarter 2024 earnings announcement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The company remains committed to its previously announced 2025 financial objectives of 4% to 5% operational sales growth and approximately
16.5% adjusted operating </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g907276g68i98.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">margin.&nbsp;The adjusted operating margin guidance does not currently include any impact from the recently announced U.S.
tariffs to be implemented on imports from Mexico, Canada and China. The company is working to quantify the expected impact of these actions, as well as identify potential mitigation opportunities, and plans to provide an update on its fourth-quarter
2024 earnings conference call. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Brent Shafer </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Shafer was appointed as Baxter&#146;s chair and interim CEO in February 2025, having previously served as lead independent director
since February 2023. Prior to joining the Baxter Board in May 2022, Mr.&nbsp;Shafer served as the chairman and CEO of Cerner Corporation from 2018 to 2021. He has worked in the healthcare industry for four decades, holding a number of senior
leadership roles at Koninklijke Philips NV, Hillrom, GE Medical Systems, Hewlett Packard&#146;s Medical Products Group and Johnson&nbsp;&amp; Johnson. He also serves on the boards of Tactile Systems Technology and Veracyte. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Nancy Schlichting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Schlichting<B> </B>was appointed as Baxter&#146;s lead independent director in February 2025 and has served as a director of the
company since December 2021. She joined the board following Baxter&#146;s acquisition of Hillrom, where she had previously served as a director. Ms.&nbsp;Schlichting is the retired president and CEO of Henry Ford Health System in Detroit, Michigan,
a <FONT STYLE="white-space:nowrap">non-profit</FONT> health care organization, serving in this role from June 2003 to January 2017. She joined Henry Ford Health System in 1998 as senior vice president and chief administrative officer, and was
promoted to executive vice president and chief operating officer from 1999 to 2003, and president and chief executive officer of Henry Ford Hospital from 2001 to 2003. Ms.&nbsp;Schlichting currently serves as a director of Walgreens Boots Alliance
and Encompass Health; a trustee of Kresge Foundation and Duke University; and vice-chair of the Duke University Health System Board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Heather
Knight </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ms. Knight was appointed as Baxter&#146;s executive vice president and chief operating officer in February 2025. In 2023, she
was named to lead the company&#146;s largest segment, Medical Products &amp; Therapies, which she continues to lead on an interim basis. From 2021-2023, she served as president of Baxter&#146;s Americas region and the company&#146;s Acute Therapies,
Clinical Nutrition and Medication Delivery business units. She joined the company in 2019 as general manager, U.S. Hospital Products. Throughout her accomplished <FONT STYLE="white-space:nowrap">30-year</FONT> career in the healthcare
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g907276g68i98.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">industry, Ms.&nbsp;Knight has held numerous roles in general management, global upstream and commercial capacities at
companies including Medtronic, Covidien, Tyco Healthcare and Kendall. She currently serves as a director of Waters Corporation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Baxter </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Every day, millions of patients, caregivers and healthcare providers rely on Baxter&#146;s leading portfolio of diagnostic, critical care,
nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. For more than 90 years, we&#146;ve been operating at the critical intersection where innovations that save and sustain lives
meet the healthcare providers who make it happen. With products, digital health solutions and&nbsp;therapies available in more than 100 countries, Baxter&#146;s employees worldwide are now building upon the company&#146;s rich heritage of medical
breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit <U>www.baxter.com</U> and follow us on <U>X</U>, <U>LinkedIn</U> and <U>Facebook</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> Financial Measures </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This release contains certain forward-looking financial measures that are not calculated in accordance with U.S. GAAP (Generally Accepted
Accounting Principles). The forward-looking <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures include forward-looking annual operational sales growth and forward-looking adjusted operating margin for 2025. Those measures are
provided on a continuing operations basis and exclude any impact of the Kidney Care segment, which is reported as a discontinued operation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Forward-looking annual operational sales growth represents the company&#146;s targeted future sales growth excluding sales to Vantive under a
manufacturing and supply agreement and assuming foreign currency exchange rates remain constant in future periods. Forward-looking adjusted operating margin excludes potential charges or gains that would be reflected as non-GAAP adjustments to
earnings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Baxter has not provided reconciliations of forward-looking annual operational sales growth to a forward-looking estimate of
annual GAAP sales growth or forward-looking adjusted operating margin to a forward-looking estimate of GAAP operating margin because the company is unable to predict with reasonable certainty the impact of legal proceedings, future business
optimization actions, separation-related costs, integration-related costs, asset impairments, unusual gains and losses, and changes in foreign currency exchange rates, and the related amounts are unavailable without unreasonable efforts (as
specified in the exception provided by Item 10(e)(1)(i)(B) of Regulation <FONT STYLE="white-space:nowrap">S-K).</FONT> In addition, Baxter believes that such reconciliations would imply a degree of precision and certainty that could be confusing to
investors. Such items could have a substantial impact on GAAP measures of financial performance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This press release </I>contains<I> forward-looking statements concerning the company&#146;s financial results (including the company&#146;s
performance for fourth-quarter and full-year 2024 and outlook for 2025) and business development and operational activities. These forward-looking statements are based on assumptions about many important factors, including those set forth in the
company&#146;s most recent filings on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> which could cause actual results to differ </I> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g907276g68i98.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>materially from those in the forward-looking statements. Forward-looking statements speak only as of the date they are
made. Readers are cautioned not to put undue reliance on forward-looking statements. Baxter&#146;s most recent filings on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and Form <FONT STYLE="white-space:nowrap">10-Q</FONT> and other SEC filings
are available on Baxter&#146;s website. Baxter undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media Contact </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stacey Eisen, (224) <FONT
STYLE="white-space:nowrap">948-5353</FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>media@baxter.com </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Contact </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Clare Trachtman, (224) <FONT
STYLE="white-space:nowrap">948-3020</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>bax-20250201.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 2/3/2025 1:21:13 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2024"
  xmlns:bax="http://www.baxter.com/20250201"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.baxter.com/20250201"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" namespace="http://xbrl.sec.gov/naics/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" namespace="http://fasb.org/us-types/2024" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bax-20250201_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bax-20250201_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bax-20250201_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="bax_DocumentAndEntityInformationTable" name="DocumentAndEntityInformationTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="bax_DocumentAndEntityInformationLineItems" name="DocumentAndEntityInformationLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="bax_CommonStock1.00PerValueMember" name="CommonStock1.00PerValueMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="bax_GlobalNotes13Due2025Member" name="GlobalNotes13Due2025Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="bax_GlobalNotes13Due2029Member" name="GlobalNotes13Due2029Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>bax-20250201_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 2/3/2025 1:21:16 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="bax-20250201.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="bax-20250201.xsd#bax_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="bax_DocumentAndEntityInformationTable" />
    <link:loc xlink:href="bax-20250201.xsd#bax_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="bax_DocumentAndEntityInformationLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="bax-20250201.xsd#bax_CommonStock1.00PerValueMember" xlink:type="locator" xlink:label="bax_CommonStock1.00PerValueMember" />
    <link:loc xlink:href="bax-20250201.xsd#bax_GlobalNotes13Due2025Member" xlink:type="locator" xlink:label="bax_GlobalNotes13Due2025Member" />
    <link:loc xlink:href="bax-20250201.xsd#bax_GlobalNotes13Due2029Member" xlink:type="locator" xlink:label="bax_GlobalNotes13Due2029Member" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="bax_DocumentAndEntityInformationTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bax_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="23.0001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="bax_CommonStock1.00PerValueMember" order="24" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="bax_GlobalNotes13Due2025Member" order="25" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="bax_GlobalNotes13Due2029Member" order="26" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="28.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="29.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="30.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="33.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="34.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="35.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="36.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="37.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="38.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="39.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="40.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="41.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="42.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="43.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="44.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="45.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="46.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="47.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="48.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="49.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="50.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="51.001" priority="2" use="optional" />
  </link:definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>bax-20250201_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 2/3/2025 1:21:13 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="bax-20250201.xsd#bax_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="bax_DocumentAndEntityInformationTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bax_DocumentAndEntityInformationTable" xlink:to="bax_DocumentAndEntityInformationTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="bax_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="bax_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Table]</link:label>
    <link:loc xlink:href="bax-20250201.xsd#bax_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="bax_DocumentAndEntityInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="bax_DocumentAndEntityInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="bax_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="bax_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="bax-20250201.xsd#bax_CommonStock1.00PerValueMember" xlink:type="locator" xlink:label="bax_CommonStock1.00PerValueMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bax_CommonStock1.00PerValueMember" xlink:to="bax_CommonStock1.00PerValueMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="bax_CommonStock1.00PerValueMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock 1.00 Per Value [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="bax_CommonStock1.00PerValueMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock 1.00 Per Value [Member]</link:label>
    <link:loc xlink:href="bax-20250201.xsd#bax_GlobalNotes13Due2025Member" xlink:type="locator" xlink:label="bax_GlobalNotes13Due2025Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bax_GlobalNotes13Due2025Member" xlink:to="bax_GlobalNotes13Due2025Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="bax_GlobalNotes13Due2025Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Global Notes 13 Due 2025 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="bax_GlobalNotes13Due2025Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Global Notes 13 Due 2025 [Member]</link:label>
    <link:loc xlink:href="bax-20250201.xsd#bax_GlobalNotes13Due2029Member" xlink:type="locator" xlink:label="bax_GlobalNotes13Due2029Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bax_GlobalNotes13Due2029Member" xlink:to="bax_GlobalNotes13Due2029Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="bax_GlobalNotes13Due2029Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Global Notes 13 Due 2029 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="bax_GlobalNotes13Due2029Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Global Notes 13 Due 2029 [Member]</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>bax-20250201_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 2/3/2025 1:21:14 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="bax-20250201.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="bax-20250201.xsd#bax_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="bax_DocumentAndEntityInformationTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="bax_DocumentAndEntityInformationTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="bax-20250201.xsd#bax_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="bax_DocumentAndEntityInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationTable" xlink:to="bax_DocumentAndEntityInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="bax-20250201.xsd#bax_CommonStock1.00PerValueMember" xlink:type="locator" xlink:label="bax_CommonStock1.00PerValueMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="bax_CommonStock1.00PerValueMember" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="bax-20250201.xsd#bax_GlobalNotes13Due2025Member" xlink:type="locator" xlink:label="bax_GlobalNotes13Due2025Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="bax_GlobalNotes13Due2025Member" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="bax-20250201.xsd#bax_GlobalNotes13Due2029Member" xlink:type="locator" xlink:label="bax_GlobalNotes13Due2029Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="bax_GlobalNotes13Due2029Member" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="48.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="49.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="50.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bax_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="51.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g907276g68i98.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g907276g68i98.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M8[)<#D&78?\ M3"0G[/GJ1GB*49QJ5).<HRC*:DG#F4-MHJUU8^%_P#@I/\
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1:W6ST>ST/U@K\C/U,* /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45319843615728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 01, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BAXTER INTERNATIONAL INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000010456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb.  01,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-4448<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">36-0781620<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Baxter Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Deerfield<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">60015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(224)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">948-2000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_CommonStock1.00PerValueMember', window );">Common Stock 1.00 Per Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $1.00 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX (NYSE)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2025Member', window );">Global Notes 13 Due 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">1.3% Global Notes due 2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX 25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2029Member', window );">Global Notes 13 Due 2029 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">1.3% Global Notes due 2029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX 29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_DocumentAndEntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_DocumentAndEntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_CommonStock1.00PerValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_CommonStock1.00PerValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M2 /W%,)^&((;9F<O&R0WV8>DLHX621A%KNE6,4DF5#YMZ XC-;'@HL[]#>E
M[PE)9F)3G5JXW UC<L%9%&)PQO?=DXR_A"L: N@F4CSS)*B>1UQS=(>A&;]W
M<</^+]I$9 H,]R^>'FU4BV(+[!:S$M=D@(M;=U[#/BPNCZ/@ N\\K_$+AF)\
MW\6=^TX$,"N3E4@PY["(7#7:Y[ \1EO3A("+>_=GR95B"4Q-'*^3O7%DE52X
MD"VR7>/]+N[14Q'Q@"N>+,D]7."2TZB2!U>Q\ABW=W&KGDB63P^##BM2&Q8W
MX#L/B\61^N%Z-C+/.+^'V_0W9*,L6P.9#= B:P4TQN^=9/S#F,FEKN<'4% K
MS9S2I'(59A&THAW< .#6K.<M7U2(X(FX%XZCUT'D$XW6C'RY9[HWJU?^;['T
M]TP&>/[;WKB@<?!:?),3'N[J4Q:LI69VO3F9<155^K%%Y+!T9^3'O'@IE>19
M%P_#-)'AX8X_DS34U^MT%\]%I?M8!.#>BKP;_SD=8KGAF=SP<,LOIVVX#58T
M6;*CMWP6(8V$$9G<\'"[_Q").4396"B6$=<G-] V>O&/]PZJ^=J+SP2+UW[;
MWD$3Y[7X)H<\/#=.[!W+?<>%_Q/YJGCAOG+8DPF32#X>'?;&L0CHQL%93/CX
M>%:<WC06(4O3^"9S?#QSCC3-%=HTN.9KGS4=/&QZV\#QWR)P?!,X_O<('(O(
MT::YPAA-VOC_-VTL GG3H"PF:?SOE306H6--4S]XJJR?T-]3O33,2,06H.-<
M7,*IRN*A=[&C1)H_:)X+I42<;ZX8A?6M/@"^7PBHR'Y'/[LN__70^Q=02P,$
M%     @ SSQ#6I^@&_"Q @  X@P   T   !X;"]S='EL97,N>&ULW5=M:]LP
M$/XK0C]@;F)JXI$8MD!AL(U"\V%?E5AV!'KQ9+ES^NNGLVPG:75EW8>QS:')
MW3VZNT=W)YFN6W>2_.'(N2.]DKK=T*-SS?LD:0]'KEC[SC1<>Z0R5C'G55LG
M;6,Y*UMP4C)9WMQDB6)"TV*M.W6G7$L.IM-N0V]H4JPKH\^6E :#7\H4)X],
M;NB62;&W8EC+E)"G8%Z"X6"DL<1Y*GQ#%V!IGP*\"!JP'.,HH8T%8Q(RA._]
MN/P9,&FM5X64,\$E#89BW3#GN-5W7AD6#\87$!GEW:GQ#&O+3HOE+3T[##\^
MR=[8DMLYS8).IF(M>05TK*B/\.M,DP#HG%%>* 6KC68#A\EC%'S8 Y?R 5KX
MK;J*W5<D].)3"6T@L-5)](1&,80)"L2_C!9B7X2]_:VPI!&/QGWL_&[TH'_O
MC./WEE>B'_2^FO-CT1=X=-8T\O1!BEHK'O;^RPF+-9O\R-%8\>2SP:0<O(%;
M2AZY=>)P:?EA6;/CO9NFJ:]PSLM_D/.?K7/--;=,7I+VH_\W5_DMC)/Q]%P<
MT:L#.EL)7(0;^A7N5WGF0/:=D$[H43N*LN3ZQ3GUX1W;^PO\*KY?7_**==+M
M9G!#S_(77HI.Y?.J>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<
MGB-WPQ-',)^ Q1' L#P8 \PG>&%Y_J?]K-#]! SCMHHB*]1GA?H$KQBR'3Y8
MGKA/[I_X3O,\3;,,J^AV&V6PQ>J69? 7CX9Q P\L#V1Z6ZWQ;N,3\OH<8#U]
M;4*PG>*3B.T4KS4@\;J!1Y['NXWE 0^L"]CL0/YX'IBIN$^:0E<Q;M@)QI$\
MQQ"8Q?B,9AE2G0P^\?Y@IR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73
M>RHY_U=3_ 102P,$%     @ SSQ#6I>*NQS     $P(   L   !?<F5L<R\N
M<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2!8I%G;^OVJ5QD L9
M>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:
M+#Y +AEFM[UD%J=SI%>(7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU
M1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'<?VD-/IKV,BM'I;Z/EQ:%0*
MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " #//$-:'#AEZC\!   \ @  #P
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M=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @ SSQ#6B0>FZ*M    ^ $
M !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<[61/0Z#, R%KQ+E #50
MJ4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_OR4Z?:!1W;J"V\R1&:P;*
M9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI
M?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI
M5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    ( ,\\0UIED'F2&0$
M ,\#   3    6T-O;G1E;G1?5'EP97-=+GAM;*V334[#,!"%KQ)E6R4N+%B@
MIAM@"UUP 6-/&JO^DV=:TMLS3MI*H!(5A4VL>-Z\SYZ7K-Z/$;#HG?78E!U1
M?!0"50=.8ATB>*ZT(3E)_)JV(DJUDUL0]\OE@U#!$WBJ*'N4Z]4SM')OJ7CI
M>1M-\$V9P&)9/(W"S&I*&:,U2A+7Q<'K'Y3J1*BY<]!@9R(N6%"*JX1<^1UP
MZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+*&4/;&@4ZJ+WCEAIC JFQ R!GZ]%T
M,4TFGC",S[O9_,%F"LC*30H1.;$$?\>=(\G=560C2&2FKW@ALO7L^T%.6X.^
MD<WC_0QI-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#
M%     @ SSQ#6@=!36*!    L0   !               ( !     &1O8U!R
M;W!S+V%P<"YX;6Q02P$"% ,4    " #//$-:,(:^[^\    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " #//$-:
MF5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( ,\\0UH$_Y0F% 4  (88   8              "
M@0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " #//$-:
MGZ ;\+$"  #B#   #0              @ %8#0  >&PO<W1Y;&5S+GAM;%!+
M 0(4 Q0    ( ,\\0UJ7BKL<P    !,"   +              "  300  !?
M<F5L<R\N<F5L<U!+ 0(4 Q0    ( ,\\0UH<.&7J/P$  #P"   /
M      "  1T1  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #//$-:)!Z;
MHJT   #X 0  &@              @ &)$@  >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    " #//$-:99!YDAD!  #/ P  $P
M    @ %N$P  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  "X
%%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d907276d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>bax-20250201.xsd</File>
    <File>bax-20250201_def.xml</File>
    <File>bax-20250201_lab.xml</File>
    <File>bax-20250201_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="d907276d8k.htm">d907276d8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="28">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d907276d8k.htm": {
   "nsprefix": "bax",
   "nsuri": "http://www.baxter.com/20250201",
   "dts": {
    "schema": {
     "local": [
      "bax-20250201.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "bax-20250201_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "bax-20250201_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bax-20250201_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d907276d8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 3,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 4,
   "entityCount": 1,
   "segmentCount": 3,
   "elementCount": 30,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 28
   },
   "report": {
    "R1": {
     "role": "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-02-01_to_2025-02-01",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d907276d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-02-01_to_2025-02-01",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d907276d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "bax_CommonStock1.00PerValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.baxter.com/20250201",
     "localname": "CommonStock1.00PerValueMember",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock 1.00 Per Value [Member]",
        "terseLabel": "Common Stock 1.00 Per Value [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "bax_DocumentAndEntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.baxter.com/20250201",
     "localname": "DocumentAndEntityInformationLineItems",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Line Items]",
        "terseLabel": "Document And Entity Information [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "bax_DocumentAndEntityInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.baxter.com/20250201",
     "localname": "DocumentAndEntityInformationTable",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Table]",
        "terseLabel": "Document And Entity Information [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "bax_GlobalNotes13Due2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.baxter.com/20250201",
     "localname": "GlobalNotes13Due2025Member",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Global Notes 13 Due 2025 [Member]",
        "terseLabel": "Global Notes 13 Due 2025 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "bax_GlobalNotes13Due2029Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.baxter.com/20250201",
     "localname": "GlobalNotes13Due2029Member",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Global Notes 13 Due 2029 [Member]",
        "terseLabel": "Global Notes 13 Due 2029 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.baxter.com//20250201/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001193125-25-018871-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-018871-xbrl.zip
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M:R0Y5Q \SB;(?^Z;:E1+ 7+"AI"EO(VHN4W@4@5*$YA-$&U'*J!(N&24I:O
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MCX"-]#X4J0T<DSP'3)O<?^@YJ>Q,[V;Y]AY&CR1P;+Z=O9DUNYPZP4R%.KZ
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MI?W:XAD"VRL>CJ&S!6.]OS=O$.4;9^ZG_08J*?)<9@1?]"3O2T\/18.#"C9
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MW*"7P@Y.P=V#]"8X! L$JTUD](%7\<6MP-B$OJ>F\K% _WL6Z*_"BJ9+L-:
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M ET +2!28]4"XTY[:8=@]N/!_IO^X>'A[N$AL1MS5/!<_*N0=SPF7,.IP0R
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M R1S;@LRK>::)V6,\Y2P2]6$;9C;8NYQS(T1D?(5.UG:G!APPS-;F7D0[KY
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MR.S[3$8@)W['94PS[K-@ 2:ATIYOU'<Z!MTTI0::!'2Y*@?F! (;N]CM@*1
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MG+A !04!H;K\S^FM)!71.Z.Q !/H8RJRW$G[@M+#;,^_TN17X7(\WWX-\IA
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M3?[5P5]^^>6']?5/;O?U./:3P[]PD?]%SO\'4$L! A0#%     @ SSQ#6G8
MH:8E!   P1$  !               ( !     &)A>"TR,#(U,#(P,2YX<V10
M2P$"% ,4    " #//$-:%QA=>-T%   S-0  %               @ %3!
M8F%X+3(P,C4P,C Q7V1E9BYX;6Q02P$"% ,4    " #//$-:<*OKX?,'  #@
M6   %               @ %B"@  8F%X+3(P,C4P,C Q7VQA8BYX;6Q02P$"
M% ,4    " #//$-:@]W_6Y0%  #\.   %               @ &'$@  8F%X
M+3(P,C4P,C Q7W!R92YX;6Q02P$"% ,4    " #//$-:/:NQAZT>  #CJP
M#@              @ %-&   9#DP-S(W-F0X:RYH=&U02P$"% ,4    " #/
M/$-:HRN#TV@9  !0;0  $0              @ $F-P  9#DP-S(W-F1E>#$P
M,2YH=&U02P$"% ,4    " #//$-:=<@@K<<,  "&00  $0
M@ &]4   9#DP-S(W-F1E>#$P,BYH=&U02P$"% ,4    " #//$-:KH0_QA 6
M  "84P  $0              @ &S70  9#DP-S(W-F1E>#DY,2YH=&U02P4&
2      @ " #] 0  \G,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>d907276d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bax="http://www.baxter.com/20250201"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bax-20250201.xsd" xlink:type="simple"/>
    <context id="duration_2025-02-01_to_2025-02-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-01</endDate>
        </period>
    </context>
    <context id="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-CommonStock1.00PerValueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock1.00PerValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-01</endDate>
        </period>
    </context>
    <context id="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-GlobalNotes13Due2025Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-01</endDate>
        </period>
    </context>
    <context id="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-GlobalNotes13Due2029Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-01</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2025-02-01_to_2025-02-01"
      id="Hidden_dei_EntityRegistrantName">BAXTER INTERNATIONAL INC</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-326">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-02-01_to_2025-02-01"
      id="Hidden_dei_EntityCentralIndexKey">0000010456</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-361">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-362">2025-02-01</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-363">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-364">1-4448</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-365">36-0781620</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-366">One Baxter Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-367">Deerfield</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-368">IL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-369">60015</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-370">(224)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-371">948-2000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-372">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-373">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-374">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-375">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-CommonStock1.00PerValueMember"
      id="ixv-376">Common Stock, $1.00 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-CommonStock1.00PerValueMember"
      id="ixv-377">BAX (NYSE)</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-CommonStock1.00PerValueMember"
      id="ixv-378">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-GlobalNotes13Due2025Member"
      id="ixv-379">1.3% Global Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-GlobalNotes13Due2025Member"
      id="ixv-380">BAX 25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-GlobalNotes13Due2025Member"
      id="ixv-381">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-GlobalNotes13Due2029Member"
      id="ixv-382">1.3% Global Notes due 2029</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-GlobalNotes13Due2029Member"
      id="ixv-383">BAX 29</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-02-01_to_2025-02-01_us-gaap-StatementClassOfStockAxis_bax-GlobalNotes13Due2029Member"
      id="ixv-384">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-02-01_to_2025-02-01" id="ixv-385">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
